9 results about "Topical cream" patented technology

This invention discloses a cream for treating psoriasis vulgaris and its preparation method: belonging to the technical field of psoriasis drug technology, this cream is made from the following raw materials in parts by weight: 1-5 parts Tripterygium wilfordii, 1-5 parts Euphorbia fischeriana, 10 parts Catechu, 8 parts Eucalyptus globulus, 10 parts Dictamnus dasycarpus, 10 parts Spatholobus suberectus, 10 parts Sophora flavescens, 10 parts Rehmannia glutinosa, 10 parts Angelica sinensis, 100-140 parts water, 40-50 parts emulsifier, and 0.05-0.1 parts preservative. The preparation method includes: decocting Tripterygium wilfordii, Euphorbia fischeriana, Catechu, Eucalyptus globulus, Dictamnus dasycarpus, Spatholobus suberectus, Sophora flavescens, Rehmannia glutinosa, and Angelica sinensis with water, then removing the herbs to obtain a medicinal paste; mixing the medicinal paste, emulsifier, and preservative and adding them to an emulsifier for emulsification to obtain the product. This formula can treat psoriasis vulgaris. As a topical cream for psoriasis, this invention has antifungal, antiviral, heat-clearing and blood-cooling, and antioxidant activities. It can inhibit epidermal cell proliferation, slow down the epidermal metabolic cycle, promote keratinization, inhibit sebum secretion, inhibit the growth environment of bacteria and fungi, and relieve itching caused by inflammation.

The invention relates to a topical cream containing a plethora of small sharp shards of a solid biopolymer (i.e., microneedles) which may or may not contain additional active ingredients or drugs, created in multiple sizes without molds or unusual processing equipment.

The present invention relates to the technical field of medical materials. Provided are a topical cream or patch for scar treatment and a preparation method therefor. The cream or patch is a topical preparation for scar treatment that combines a hormone, an antibiotic and a chemotherapeutic drug. By means of the synergistic effect of the three components, the cream or patch realizes a variety of effects such as sterilization, anti-inflammation, inhibition of fibroblast proliferation and angiogenesis, inhibition of scar hyperplasia, promotion of scar softening, and prevention of infection, thereby improving the efficacy of scar treatment. The preparation can be simply applied topically or used as a patch without injection, which greatly facilitates patient use and achieves the aim of scar prevention and treatment, thereby providing a multi-functional, safe and effective approach for scar treatment.

The invention is implemented into the category of transdermal topical agents for use in regulating the dilation of blood vessels. The IP-6, Inositol, and colloidal oatmeal Nerve Relaxing Transdermal Topical Cream, Gel, or Ointment for Raynaud's Syndrome is the first topical cream containing any or all of the following: IP-6, inositol, and colloidal oatmeal, with IP-6 as the carrier agent. The present invention will allow for the decrease in the time to full clinical effect, eliminate having to wear a patch of paper over the application site, and eliminate the problem of skin irritation due to the IP-6 delivering the colloidal oatmeal to the application area to provide extra soothing and moisturizing properties. The present invention is specifically and uniquely designed for ease of use and quick action of full clinical effect with the relaxation of nerve endings that lead to dilation of extremely constricted blood vessels in mind.

The invention discloses emulsifiable paste for treating eczema and dermatitis (seborrheic dermatitis) and a preparation method thereof, and belongs to the technical field of eczema and dermatitis (seborrheic dermatitis) medicines, the emulsifiable paste is prepared from the following raw materials in parts by weight: 6-10 parts of rhinacanthus nasutus, 6-10 parts of jatropha curcas, 6-10 parts of catechu, 6-10 parts of breynia fruticosa, 15-20 parts of coal tar, 40-80 parts of water, 40-50 parts of an emulsifier and 0.05-0.1 part of a preservative. The preparation method comprises the following steps: decocting the rhinacanthus nasutus, the jatropha curcas, the catechu and the breynia fruticosa with water, and then fishing out the medicinal materials to obtain medicine slurry; and mixing the medicine slurry, coal tar, an emulsifier and a preservative, adding into an emulsifying machine, and emulsifying to obtain the product. The external emulsifiable paste for eczema and dermatitis (seborrheic dermatitis) has the effects of astringing ulcers, astringing wounds and stopping bleeding, resisting viruses, dissipating blood stasis and diminishing swelling, relieving pain and itching, controlling pathogenic organisms on skin, promoting skin repair, inhibiting reproduction of viruses and fungi and the like.

This disclosure describes a cannabinoid-based nanoplatform for treating shingles, designed to enhance bioavailability and controlled release of active ingredients. The composition includes cannabinoids like cannabidiol (CBD) and cannabigerol (CBG), alongside flavonoids, polyphenols, and alkaloids, in oral and topical formulations. The oral capsule combines cannabinoids with polyphenols and flavonoids to provide systemic anti-inflammatory, antiviral, and neuroprotective effects, particularly for nerve pain and inflammation, including postherpetic neuralgia. The topical cream includes cannabinoids, capsaicin, and aloe vera, offering localized relief from pain, itching, and rash. The method targets both systemic and localized symptoms during the acute phase of shingles, aiming to inhibit varicella-zoster virus replication, disrupt viral assembly, and prevent viral release, while also providing immune modulation and anti-inflammatory benefits. The nanoplatform uses nano-emulsification techniques, producing particles smaller than 200 nm to ensure optimal delivery and therapeutic efficacy, offering comprehensive relief for shingles symptoms.

A topical cream or ointment is provided that provides for the binding to CB1 and / or CB2 receptors for the soothing of pain, inflammation of smooth muscle, tendons, ligaments, skeletal muscle, endothelial cell, synovial cell, peripheral nerve fibers, reduction of endothelial bruising, promotion of healing of endothelial bruising, and dermatological itch sensation wherein the improvement comprises providing the effect of cannabinoid using plant extracts. A topically administered formulation is also provided for treating anal mucosal inflammation, soothing of pain, inflammation of anal mucosal inflammation; reducing keratinocyte apoptosis; treating viral-associated epithelial damage, treating radiation dermatitis; and treating chemotherapy-induced dermatitis.

A topical cream or ointment is provided that provides for the binding to CB1 and / or CB2 receptors for the soothing of pain, inflammation of smooth muscle, tendons, ligaments, skeletal muscle, endothelial cell, synovial cell, peripheral nerve fibers, reduction of endothelial bruising, promotion of healing of endothelial bruising, and dermatological itch sensation wherein the improvement comprises providing the effect of cannabinoid using plant extracts.

The topical composition includes an amount of an antibiotic and a carrier that has skin penetration enhancement properties. The composition can include about 5 wt % Lidocaine, about 5 wt % Ketoprofen and about 5 wt % Doxycycline. The composition is readily formed as a consumer package. The composition has efficacy as a bite treatment and in particular bacteria conveyed via a tick bite.